Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (1020)	7/23/1997 2:41:00 AM
From: billkirn	of 6136

Hi John W. New Scrips of 4,247 for week ending July 11! Using your numbers from post 898: New sc. After Total per wk. 1 year Revenue 4,000 244,000 1,220M If this holds up, do you expect revenue to be $1.22 Billion over the next 12 months??? If they can get 25% to the bottom line= $405 million earnings If shares expand to 20 million then... $20 per share earnings over the next 12 months...!!! PE of 15 = $300 per share PE of 30 = $600 per share Any obvious faults with this calculation?? Woof! Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next